Can we use Patient-derived Xenografts to Assess New Lymphoma Therapies?

Can we use Patient-derived Xenografts to Assess New Lymphoma Therapies?

User Photo
HMP CME

4 years
351 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from "Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies", Dr. Giorgio Inghirami discusses whether or not we can use patient-derived xenografts to assess new lymphoma therapies.

A continuing education program is offered as a supplement to this webcast at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=LM2015EP

© 2015 Imedex, LLC.
Up Next Autoplay
>